Januvia Uses
Links shared publicly online about this topic
Sitagliptin (marketed as Januvia and Janumet) - acute pancreatitis
fda.gov — “Cases of acute pancreatitis reported in patients treated with sitagliptin.” View full resource at fda.gov
Most Recently Shared on September 25, 2009 at 4:03 pm By:
Is Januvia more effective than Byetta? - Medpedia
medpedia.com — “3 Answers. One (Januvia) is more convenient to use than the injectable Byetta. Hence my question.” View full resource at medpedia.com
Most Recently Shared on December 1, 2009 at 12:47 am By:
"Is Januvia more effective than Byetta?" #diabetes http://bit.ly/5PUfl1
FDA links Januvia to pancreatitis - FiercePharma
fiercepharma.com — “Concerned by post-marketing cases of pancreatitis, FDA is adding the reports to labeling on Merck's (MRK) diabetes drug Januvia (sitagliptin) and a combo form of the drug, Janumet. The agency is... Read more...” View full resource at fiercepharma.com
Most Recently Shared on September 30, 2009 at 6:48 pm By:
RT @safety_alertss: #Drug #PtSafety #FDA links Januvia to pancreatitis Merck's #diabetes medication, new use #labeling. http://ow.ly/rLrk
FDA Alert: Sitagliptin (marketed as Januvia and Janumet) - acute pancreatitis
drugs.com — “FDA Alert: Sitagliptin (marketed as Januvia and Janumet) - acute pancreatitis” View full resource at drugs.com
Most Recently Shared on September 26, 2009 at 4:42 am By:
FDA Alert - FDA Revises Januvia/Janumet Prescribing Information to Include Reported Cases of Acute Pancreatitis - http://bit.ly/QlRRO
FDA Alert: Sitagliptin (marketed as Januvia and Janumet) - acute pancreatitis
drugs.com — “FDA Alert: Sitagliptin (marketed as Januvia and Janumet) - acute pancreatitis” View full resource at drugs.com
Most Recently Shared on September 26, 2009 at 7:03 pm By:
FDA notified healthcare professionals of revisions to include information on reported cases of acute pancreatitis....http://short.to/rthu
Januvia, Diaformin XR, Metformin ... pills pills pills! - TuDiabetes
tudiabetes.org — “I've been Type 2 for nearly ten years, with good control using diet and exercise. Eventually, though, things got out of hand, I pulled out an HbA1c of 11.2, and Metformin was prescribed by my GP. Three months later, my HbA1c is down to 8.0 which I'm feeling pretty happy about. Today I went to see my specialist for the first time since starting the Metformin. It was a good appointment (I'm lucky to have a very good endo!), and he praised my recent weight loss efforts, and the drop in my sugars. M” View full resource at tudiabetes.org
Most Recently Shared on August 31, 2010 at 9:23 am By:
Type 2 #diabetes: Januvia, Diaformin XR, Metformin ... pills pills pills!: I've been Type 2 for nearly ten years, ... http://bit.ly/8ZKPiI
Merck Receives Positive CHMP Opinion For JANUVIA® (sitagliptin) And JANUMET® (sitagliptin/metformin)
medicalnewstoday.com — “Merck & co., inc., which operates in many countries as merck sharp & dohme (msd), has received a positive opinion from the european medicines agency's (emea) committee for medicinal products for h” View full resource at medicalnewstoday.com
Most Recently Shared on September 26, 2009 at 11:42 am By:
Merck Receives Positive CHMP Opinion For JANUVIA® (sitagliptin) And JANUMET® (sitagliptin/metformin): Merck & C.. http://bit.ly/4KL2j
Januvia & Janumet tablets use as "add-on to insulin for the treatment of type 2 diabetes" in European Union - TuDiabetes
tudiabetes.com — “The European Medicines Agency’s (EMEA) Committee for Medicinal Products for Human Use (CHMP) is recommending Merck & Co., Inc.'s Januvia and Janumet tablets use as add-on to insulin for the treatment of type 2 diabetes. If adopted by the European Commission, sitagliptin will be the only diabetes treatment in the DPP-4 inhibitor class to have an indication for use as add-on to insulin in the European Union. (See the following link of Sept. 28th.) Also, the following link says in part t” View full resource at tudiabetes.com
Most Recently Shared on September 28, 2009 at 12:55 pm By:
Type 2 diabetes: Januvia & Janumet tablets use as "add-on to insulin for the treatment of type .. http://bit.ly/mbEpx
No pancreatitis risk seen in Byetta, Januvia drugs: NEW YORK (Reuters) - Two widely used diabetes medicines, Januv... http://bit.ly/bd2VYt
reuters.com — “No pancreatitis risk seen in Byetta, Januvia drugs: NEW YORK (Reuters) - Two widely used diabetes medicines, Januv... http://bit.ly/bd2VYt” View full resource at reuters.com
Most Recently Shared on June 28, 2010 at 11:25 pm By:
No pancreatitis risk seen in Byetta, Januvia drugs: NEW YORK (Reuters) - Two widely used diabetes medicines, Januv... http://bit.ly/bd2VYt
Merck Receives Positive CHMP Opinion For JANUVIA(R) (sitagliptin) And JANUMET(R) (sitagliptin/metformin) As Add-On To Insulin In The European Union
medicalnewstoday.com — “Merck & co., inc., which operates in many countries as merck sharp & dohme (msd), has received a positive opinion from the european medicines agency's (emea) committee for medicinal products for h” View full resource at medicalnewstoday.com
Most Recently Shared on September 28, 2009 at 2:08 pm By:
Merck Receives Positive CHMP Opinion For JANUVIA(R) (sitagliptin) And JANUMET(R) (sitagliptin/metformin) As Add.. http://bit.ly/kuFvK
Merck News Item
merck.com — “Merck News Item” View full resource at merck.com
Most Recently Shared on June 28, 2010 at 1:37 pm By:
Post-Hoc Analysis of JANUVIA® Compared w/Sulfonylurea on Composite Endpoint of Lower Blood Sugar - http://ow.ly/248cl
Suspect that I'm LADA...endo does not! - TuDiabetes
tudiabetes.org — “Hello, I am new and could use some advice! I was diagnosed with T2 a year ago following gestational diabetes. My A1C was 6.0 but GTT numbers were sky-high. A complete change of diet, adding high intensity exercise and dropping my BMI down to 19 resulted in....A1C of 6.0, followed by 6.1. Endo would like me at 5.7 maximum, for the long term benefits (I am in my 30's) and added Januvia three months ago, which I was very reluctant to take (I am wary of long term effects). Have not had my latest A1C” View full resource at tudiabetes.org
Most Recently Shared on June 10, 2010 at 8:17 pm By:
LADA diabetes: Suspect that I'm LADA...endo does not!: Hello, I am new and could use some advice! I was diagnosed... http://bit.ly/cNnl78
Popular Diabetes Treatment Could Trigger Pancreatitis, Pancreatic Cancer
newswise.com — “A drug widely used to treat Type 2 diabetes may have unintended effects on the pancreas that could lead to a form of low-grade pancreatitis in some patients and a greater risk of pancreatic cancer in long-term users. Sitagliptin, sold in pill form as Januvia, caused abnormalities in the pancreas of some test rats.” View full resource at newswise.com
Most Recently Shared on April 30, 2009 at 9:10 pm By:
Popular Diabetes Treatment Could Trigger Pancreatitis, Pancreatic Cancer http://bit.ly/xBf4b
Type 2 Diabetes Medication - Medication Reference Chart For Type 2 Diabetes
diabetes.about.com — “There are new medications approved to treat Type 2 diabetes. They are completely new categories of drugs. Januvia, Byetta, and Symlin work in completely different ways than the standard medications. The older classifications of drugs are still being used, sometimes in combination with the newest ones.” View full resource at diabetes.about.com
Most Recently Shared on May 10, 2011 at 10:43 am By:
Medication Reference Chart: There are new medications approved to treat Type 2 diabetes. They are completely new... http://bit.ly/k7q6vB
DPP-4 Inhibitors :: Diabetes Self-Management
diabetesselfmanagement.com — “In 2006, a new class of medicine for Type 2 diabetes was introduced to the U.S. market. Called DPP-4 inhibitors, these drugs work in a way that is different from any previous diabetes treatment. Sitagliptin (brand name Januvia) is the first drug in this class to be approved; it can be used alone or in combination with other oral diabetes drugs. Saxagliptin (Onglyza), another DPP-4 inhibitor, received approval in August 2009...” View full resource at diabetesselfmanagement.com
Most Recently Shared on August 12, 2009 at 7:05 pm By:
#diabetes Article of the Week: DPP-4 Inhibitors: A Novel Class of Drugs for Type 2 Diabetes http://bit.ly/19Q8o8
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Featuring the top 3 experts for this topic
-
eyeonfda
Author of the blog Eye on FDA - www.eyeonfda.com
-
The Medpedia Project
Medpedia is a long-term project to advance collaborative, transparent health and medical knowledge.
-
Barbara Olson
A nurse with an engineer's mind tweeting #ptsafety-sensitive things that strike my fancy. (Tweets do not represent my employer.)
Advertisement

